海南海药
(000566)
| 流通市值：59.93亿 | | | 总市值：66.68亿 |
| 流通股本：11.66亿 | | | 总股本：12.97亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 990,701,458.53 | 804,727,228.88 | 593,434,411.11 | 363,023,438.22 |
| 营业收入 | 990,701,458.53 | 804,727,228.88 | 593,434,411.11 | 363,023,438.22 |
| 二、营业总成本 | 1,398,076,695.25 | 1,052,560,731.35 | 745,391,077.59 | 382,317,219.15 |
| 营业成本 | 641,692,184.13 | 524,945,670.96 | 393,444,076.44 | 221,575,117.05 |
| 税金及附加 | 19,233,165.83 | 13,927,302.34 | 11,266,534.71 | 4,955,214.87 |
| 销售费用 | 274,387,197.78 | 204,087,357.24 | 146,082,957.92 | 55,263,477.03 |
| 管理费用 | 228,414,014.42 | 129,730,553.1 | 79,980,570.25 | 44,924,739.69 |
| 研发费用 | 58,621,438.42 | 57,982,852.49 | 33,739,370.27 | 22,999,618.72 |
| 财务费用 | 175,728,694.67 | 121,886,995.22 | 80,877,568 | 32,599,051.79 |
| 其中:利息费用 | 176,506,755.8 | 122,362,317.82 | 82,323,905.07 | 38,473,113.51 |
| 其中:利息收入 | 717,119.06 | 649,961.52 | 1,432,420.69 | 6,052,951.07 |
| 加:公允价值变动收益 | -357,385,227.15 | -296,895.03 | -58,709.72 | 82,544.81 |
| 加:投资收益 | -68,356,604.55 | -50,014,917 | -51,723,755.44 | 1,521,859.57 |
| 资产处置收益 | 944,867.89 | -3,729.01 | -3,729.01 | -23,423.97 |
| 资产减值损失(新) | -361,749,130.19 | -5,478,791.34 | -345,992.39 | 46,994.92 |
| 信用减值损失(新) | -386,844,025.77 | -24,930,199.91 | -24,374,761.5 | -4,850,349.9 |
| 其他收益 | 30,816,706.34 | 23,498,856.8 | 21,958,849.99 | 2,607,514.61 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -1,549,948,650.15 | -305,059,177.96 | -206,504,764.55 | -19,908,640.89 |
| 加:营业外收入 | 816,403.1 | 4,440,357.69 | 500,809.85 | 268,027.5 |
| 减:营业外支出 | 12,031,660.79 | 8,043,374.34 | 6,221,917.14 | 1,037,097.71 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -1,561,163,907.84 | -308,662,194.61 | -212,225,871.84 | -20,677,711.1 |
| 减:所得税费用 | 34,036,741.57 | 5,016,730.56 | 638,819.23 | 3,773,582.97 |
| 六、净利润 | -1,595,200,649.41 | -313,678,925.17 | -212,864,691.07 | -24,451,294.07 |
| 持续经营净利润 | -1,595,200,649.41 | -313,678,925.17 | -212,864,691.07 | -24,451,294.07 |
| 终止经营净利润 | 0 | - | 0 | - |
| 归属于母公司股东的净利润 | -1,525,200,923.81 | -295,188,939.35 | -200,309,364.53 | -15,842,321.07 |
| 少数股东损益 | -69,999,725.6 | -18,489,985.82 | -12,555,326.54 | -8,608,973 |
| (一)基本每股收益 | -1.18 | -0.23 | -0.15 | -0.01 |
| (二)稀释每股收益 | -1.18 | -0.23 | -0.15 | -0.01 |
| 八、其他综合收益 | -3,699,459.01 | -348,076.72 | 444,869.03 | 27,503.46 |
| 归属于母公司股东的其他综合收益 | -1,737,909.01 | -348,076.72 | 444,869.03 | 27,503.46 |
| 九、综合收益总额 | -1,598,900,108.42 | -314,027,001.89 | -212,419,822.04 | -24,423,790.61 |
| 归属于母公司股东的综合收益总额 | -1,526,938,832.82 | -295,537,016.07 | -199,864,495.5 | -15,814,817.61 |
| 归属于少数股东的综合收益总额 | -71,961,275.6 | -18,489,985.82 | -12,555,326.54 | -8,608,973 |
| 公告日期 | 2025-04-12 | 2024-10-31 | 2024-08-30 | 2024-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |